Delen, V.Ediz, L.Alpaycı, M.2025-05-102025-05-1020211301-088310.5505/ejm.2021.713632-s2.0-85111664779https://doi.org/10.5505/ejm.2021.71363https://hdl.handle.net/20.500.14720/5635This study aims to assess the clinical efficacy of intra-articular platelet-rich plasma injections in symptomatic meniscus tears of the knee. Forty one patients (12 males, 29 females; mean age 38.2±8.37 years; range 21 to 50 years) with meniscal tear included in the study. Lateral patellofemoral approach was used for intra-articular platelet-rich plasma injections. The platelet-rich plasma applications were performed three times one week apart. Patients were evaluated usingVisual Analogue Scale (VAS) and Lequesne Index. Baseline scores were obtained pre-first injection and compared to satisfaction scores one-and four-weeks post-last injections. Compared with pre-treatment, at post-treatment weeks 1 and 4, both VAS and Lequesne Index scores significantly decreased (p<0.001). Also, compared with post-treatment week 1, at post-treatment week 4, both VAS and Lequesne Index scores significantly decreased (p<0.001). Our study results suggest that platelet-rich plasma injections improve pain and disability in patients with meniscus tears of the knee. © 2021, Yuzuncu Yil Universitesi Tip Fakultesi. All rights reserved.eninfo:eu-repo/semantics/openAccessIntra-ArticularKneeMeniscal TearMeniscusPlatelet-Rich PlasmaArticle263N/AQ4367370450355